ATE248156T1 - Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen - Google Patents

Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen

Info

Publication number
ATE248156T1
ATE248156T1 AT99916599T AT99916599T ATE248156T1 AT E248156 T1 ATE248156 T1 AT E248156T1 AT 99916599 T AT99916599 T AT 99916599T AT 99916599 T AT99916599 T AT 99916599T AT E248156 T1 ATE248156 T1 AT E248156T1
Authority
AT
Austria
Prior art keywords
acyltaxols
resistant cells
treat multidrug
multidrug
treat
Prior art date
Application number
AT99916599T
Other languages
English (en)
Inventor
Christopher K Murray
Qun Y Zheng
Sagar R Shakya
Original Assignee
Hauser Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hauser Inc filed Critical Hauser Inc
Application granted granted Critical
Publication of ATE248156T1 publication Critical patent/ATE248156T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT99916599T 1998-04-10 1999-04-09 Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen ATE248156T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/058,036 US6136988A (en) 1998-04-10 1998-04-10 7-hexanoyltaxol and methods for preparing the same
PCT/US1999/007880 WO1999052887A1 (en) 1998-04-10 1999-04-09 7-hexanoyltaxol and methods for preparing the same

Publications (1)

Publication Number Publication Date
ATE248156T1 true ATE248156T1 (de) 2003-09-15

Family

ID=22014264

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99916599T ATE248156T1 (de) 1998-04-10 1999-04-09 Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen

Country Status (8)

Country Link
US (3) US6136988A (de)
EP (1) EP1070057B1 (de)
JP (1) JP2002511457A (de)
AT (1) ATE248156T1 (de)
AU (1) AU757211B2 (de)
CA (1) CA2327791A1 (de)
DE (1) DE69910755T2 (de)
WO (1) WO1999052887A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795909A (en) 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same
DE60004630T2 (de) * 1999-01-12 2004-06-17 Quanam Medical Corp., Santa Clara Arzneimittel und verfahren zur verabreichung von wasserunlöslichen paclitaxelderivaten
US7235583B1 (en) 1999-03-09 2007-06-26 Luitpold Pharmaceuticals, Inc., Fatty acid-anticancer conjugates and uses thereof
JP2002538224A (ja) * 1999-03-09 2002-11-12 プロタルガ，インコーポレーテッド 脂肪酸−抗癌剤複合体およびこの使用
JP2003502290A (ja) * 1999-05-28 2003-01-21 ブリストル−マイヤーズ スクイブ カンパニー ジアルキルジクロロシランを用いるパクリタキセルの半合成
CO5280224A1 (es) * 2000-02-02 2003-05-30 Univ Florida State Res Found Taxanos sustituidos con ester en c7, utiles como agentes antitumorales y composiciones farmaceuticas que los contienen
JP2003522169A (ja) * 2000-02-02 2003-07-22 フロリダ・ステイト・ユニバーシティ・リサーチ・ファウンデイション・インコーポレイテッド 抗腫瘍剤としてのｃ７ヘテロ置換アセテートタキサン
US6624317B1 (en) * 2000-09-25 2003-09-23 The University Of North Carolina At Chapel Hill Taxoid conjugates as antimitotic and antitumor agents
US20070113575A1 (en) * 2003-12-05 2007-05-24 Ritchie Engineering Company, Inc. Valve manifold assembly
CN1960721A (zh) 2004-03-05 2007-05-09 佛罗里达州立大学研究基金有限公司 C7乳酰氧基取代的紫杉烷类
US7449196B2 (en) * 2004-07-09 2008-11-11 Robert Sabin Anti tumor compositions and methods of use
US20080081051A1 (en) * 2006-09-28 2008-04-03 Robert Sabin Method of manufacturing anti-tumor and anti-viral compositions
CN101735179B (zh) * 2008-11-19 2012-09-12 上海百灵医药科技有限公司 一种多烯紫杉醇的制备方法，其中间体及制备方法
CN103242267B (zh) * 2012-02-03 2015-03-18 福建南方制药股份有限公司 卡巴他赛及其中间体的制备方法及卡巴他赛中间体

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4039319A1 (de) 1990-12-10 1992-06-11 Sicowa Verfahrenstech Verfahren zum herstellen von gipsbaustoffen
US5283253A (en) * 1991-09-23 1994-02-01 Florida State University Furyl or thienyl carbonyl substituted taxanes and pharmaceutical compositions containing them
US5243045A (en) * 1991-09-23 1993-09-07 Florida State University Certain alkoxy substituted taxanes and pharmaceutical compositions containing them
US5250683A (en) * 1991-09-23 1993-10-05 Florida State University Certain substituted taxanes and pharmaceutical compositions containing them
US5227400A (en) * 1991-09-23 1993-07-13 Florida State University Furyl and thienyl substituted taxanes and pharmaceutical compositions containing them
US5721268A (en) * 1991-09-23 1998-02-24 Florida State University C7 taxane derivatives and pharmaceutical compositions containing them
US5284865A (en) * 1991-09-23 1994-02-08 Holton Robert A Cyclohexyl substituted taxanes and pharmaceutical compositions containing them
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
WO1994005282A1 (en) * 1992-09-04 1994-03-17 The Scripps Research Institute Water soluble taxol derivatives
US5380751A (en) * 1992-12-04 1995-01-10 Bristol-Myers Squibb Company 6,7-modified paclitaxels
US5580899A (en) 1995-01-09 1996-12-03 The Liposome Company, Inc. Hydrophobic taxane derivatives
US6136988A (en) * 1998-04-10 2000-10-24 Hauser, Inc. 7-hexanoyltaxol and methods for preparing the same

Also Published As

Publication number Publication date
AU3488899A (en) 1999-11-01
AU757211B2 (en) 2003-02-06
US20030083367A1 (en) 2003-05-01
US6136988A (en) 2000-10-24
DE69910755D1 (de) 2003-10-02
JP2002511457A (ja) 2002-04-16
US6753345B2 (en) 2004-06-22
US6469050B1 (en) 2002-10-22
EP1070057B1 (de) 2003-08-27
EP1070057A4 (de) 2001-09-05
CA2327791A1 (en) 1999-10-21
WO1999052887A1 (en) 1999-10-21
DE69910755T2 (de) 2004-07-01
EP1070057A1 (de) 2001-01-24

Similar Documents

Publication Publication Date Title
NO985377D0 (no) FremgangsmÕte for Õ fremstille polyalkenaminer
DE69534975D1 (de) Verwendung von noribogain derivaten zur behandlung von chemischer abhängigkeit bei säugern
ES2175087T3 (es) Compuestos triciclicos utiles en el tratamiento de trastornos de proliferacion celular.
ATE336239T1 (de) Neue fettsäureanaloge zur behandlung des bluthochdrucks
DE60027016D1 (de) Verwendung von konjugierten linolensaüren zur topischen behandlung von zellulitis
DE69910755D1 (de) Verwendung von 7-acyltaxolen zur behandlung von multidrugresistenten zellen
ATE226430T1 (de) Verfahren zur herstellung hydro-monobenzoporhyrin photosensibilisatoren enthaltender liposomen
DE69619443D1 (de) Ungesättigte Hydroxycarbonsäureverbindungen als Zwischenprodukte zur Herstellung von Schmierstoff- und Kraftstoffadditiven
AU6894800A (en) Caspase inhibitors and uses thereof
ATE239008T1 (de) Verfahren zur herstellung von (+/-) calanolide a und zwischenprodukte dafür
DK0667856T3 (da) Nye D-vitaminanaloger
YU47100A (sh) Novi derivati dihidroksiheksanoinske kiseline
BR9408392A (pt) Derivados de ácidos arilacéticos e sua utilização como fungicidas
ATE284217T1 (de) Verwendung von sulphoquinovosyldiacylglycerols zur behandlung von entzündlichen hauterkrankungen
ATE289816T1 (de) Verwendung von mirtazapine zur herstellung eines medikaments zur behandlung von schlafapnoen
AU693682B2 (en) Cancerous metastasis inhibitor
DE69629023D1 (de) Piperazino-derivative als neurokininantagonisten
BR0114884A (pt) Compostos calcilìticos
ATE236895T1 (de) Ringannelierte dihydropyrane, verfahren zur herstellung sowie deren verwendung
ATE202071T1 (de) Verfahren zur herstellung von alph-beta- ungesättigten trifluormethylcarboxylverbindungen
ATE282594T1 (de) Verfahren zur herstellung von (+)-trans-4-p- fluorophenyl-3-hydroxymethyl-1-methylpiperidin
ID27440A (id) Proses untuk menyiapkan penengah-penengah
AU2068895A (en) Dl- di- or tri-hydroxyphenylglycine alkyl esters for the treatment of inflammatory and allergic conditions
ATE249450T1 (de) Verfahren zur herstellung von l-ascorbinsäure
ATE265854T1 (de) Azasteroidverbindung zur behandlung oder vorbeugung von prostatakrebs

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties